Teleflex (TFX) to Release Quarterly Earnings on Thursday

Teleflex (NYSE:TFX) is set to issue its quarterly earnings data before the market opens on Thursday, August 1st. Analysts expect the company to announce earnings of $3.33 per share for the quarter. Teleflex has set its FY24 guidance at $13.60-13.95 EPS.Parties that wish to listen to the company’s conference call can do so using this link.

Teleflex (NYSE:TFX) last announced its earnings results on Thursday, May 2nd. The medical technology company reported $3.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.07 by $0.14. Teleflex had a return on equity of 14.78% and a net margin of 9.82%. The firm had revenue of $737.80 million during the quarter, compared to analyst estimates of $726.85 million. During the same period last year, the firm posted $3.09 EPS. The business’s revenue was up 3.8% compared to the same quarter last year. On average, analysts expect Teleflex to post $14 EPS for the current fiscal year and $15 EPS for the next fiscal year.

Teleflex Trading Up 1.1 %

Shares of TFX opened at $222.63 on Tuesday. The business has a 50-day moving average of $212.58 and a 200 day moving average of $221.63. Teleflex has a fifty-two week low of $177.63 and a fifty-two week high of $257.85. The firm has a market cap of $10.49 billion, a P/E ratio of 35.74, a price-to-earnings-growth ratio of 2.13 and a beta of 1.13. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.41 and a current ratio of 2.51.

Teleflex Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, June 14th. Investors of record on Wednesday, May 15th were issued a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 0.61%. The ex-dividend date of this dividend was Tuesday, May 14th. Teleflex’s dividend payout ratio (DPR) is currently 21.83%.

Analyst Ratings Changes

Several brokerages have commented on TFX. Truist Financial raised their target price on Teleflex from $235.00 to $240.00 and gave the stock a “hold” rating in a research note on Tuesday, July 16th. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research report on Friday, May 3rd. Finally, Piper Sandler upgraded Teleflex from a “neutral” rating to an “overweight” rating and boosted their target price for the stock from $205.00 to $245.00 in a research report on Monday, July 1st. Three research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $263.14.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.